Stephan Stilgenbauer Selected Research

B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)

10/2022	Evaluation of vecabrutinib as a model for noncovalent BTK/ITK inhibition for treatment of chronic lymphocytic leukemia.
6/2022	Efficacy and Safety of Tirabrutinib and Idelalisib With or Without Obinutuzumab in Relapsed Chronic Lymphocytic Leukemia.
4/2022	Efficacy and Safety of the Combination of Tirabrutinib and Entospletinib With or Without Obinutuzumab in Relapsed Chronic Lymphocytic Leukemia.
1/2022	Clonal evolution in chronic lymphocytic leukemia is scant in relapsed but accelerated in refractory cases after chemo(immune) therapy.
1/2022	The CLL12 trial: ibrutinib vs placebo in treatment-naïve, early-stage chronic lymphocytic leukemia.
1/2022	Identification of recurrent genomic alterations in the apoptotic machinery in chronic lymphocytic leukemia patients treated with venetoclax monotherapy.
1/2022	Integrative prognostic models predict long-term survival after immunochemotherapy in chronic lymphocytic leukemia patients.
1/2022	Sequential treatment with bendamustine, obinutuzumab (GA101) and Ibrutinib in chronic lymphocytic leukemia (CLL): final results of the CLL2-BIG trial.
1/2022	The scaffold protein NEDD9 is necessary for leukemia-cell migration and disease progression in a mouse model of chronic lymphocytic leukemia.
1/2022	Correction to: Allogeneic hematopoietic cell transplantation for patients with TP53 mutant or deleted chronic lymphocytic leukemia: results of a prospective observational study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stephan Stilgenbauer Research Topics

Disease

154	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 10/2022 - 08/2002
48	Neoplasms (Cancer) 10/2022 - 01/2003
21	Disease Progression 01/2022 - 01/2004
18	Lymphoma (Lymphomas) 08/2021 - 11/2006
15	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 10/2021 - 10/2003
13	Infections 11/2021 - 06/2013
12	Leukemia 01/2022 - 10/2004
11	Residual Neoplasm 01/2022 - 10/2004
10	B-Cell Lymphoma (Lymphoma, B Cell) 02/2022 - 09/2015
8	Neutropenia 01/2020 - 03/2014
7	Chromosome Aberrations (Chromosome Abnormalities) 01/2020 - 01/2004
7	Lymphadenopathy 11/2019 - 08/2004
6	Non-Hodgkin Lymphoma (Lymphosarcoma) 10/2021 - 08/2013
5	COVID-19 01/2022 - 01/2020
5	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021 - 08/2010
5	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2020 - 09/2015
4	Pneumonia (Pneumonitis) 01/2022 - 01/2017
4	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022 - 01/2015
4	Carcinogenesis 10/2015 - 11/2008
3	Hemorrhage 01/2022 - 08/2015
3	T-Cell Prolymphocytic Leukemia (Leukemia, T Cell, Chronic) 01/2022 - 06/2013
3	Inflammation (Inflammations) 01/2021 - 10/2017
3	Febrile Neutropenia 01/2021 - 08/2016
3	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 06/2020 - 01/2015
3	Diarrhea 01/2019 - 08/2015
2	Atrial Fibrillation 01/2022 - 11/2021
2	Sepsis (Septicemia) 01/2021 - 01/2020
2	Multiple Myeloma 01/2021 - 07/2003
2	Genomic Instability 01/2021 - 06/2016
2	Trisomy (Trisomies) 01/2020 - 01/2004
2	Anemia 12/2018 - 02/2006
2	Hematologic Neoplasms (Hematological Malignancy) 12/2018 - 04/2013
2	Fever (Fevers) 12/2018 - 01/2017
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2018 - 12/2015
2	T-Cell Leukemia (Leukemia, T Cell) 01/2018 - 06/2013

Drug/Important Bio-Agent (IBA)

32	Rituximab (Mabthera)FDA Link 02/2022 - 01/2010
28	fludarabineIBA 01/2022 - 08/2004
24	ibrutinibIBA 10/2022 - 08/2013
21	venetoclaxIBA 01/2022 - 06/2016
20	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2022 - 02/2006
18	obinutuzumabIBA 06/2022 - 03/2014
15	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2006
12	Bendamustine Hydrochloride FDA Link 01/2022 - 09/2011
11	Agammaglobulinaemia Tyrosine KinaseIBA 10/2022 - 08/2013
10	idelalisibIBA 06/2022 - 03/2014
10	Immunoglobulins (Immunoglobulin)IBA 11/2021 - 08/2002
10	ofatumumab FDA Link 01/2021 - 04/2010
7	Lenalidomide (CC 5013)FDA Link 01/2021 - 12/2011
7	Biological ProductsIBA 01/2021 - 08/2002
7	Chlorambucil (Leukeran)FDA Link 01/2020 - 10/2009
6	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 01/2022 - 02/2006
6	MicroRNAs (MicroRNA)IBA 01/2022 - 11/2008
6	Biomarkers (Surrogate Marker)IBA 01/2019 - 08/2008
6	Alemtuzumab (Campath)FDA Link 03/2017 - 09/2006
5	AutoantigensIBA 10/2021 - 12/2018
5	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 01/2004
4	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2022 - 08/2016
4	Prednisone (Sone)FDA LinkGeneric 02/2022 - 08/2016
4	Pharmaceutical PreparationsIBA 01/2022 - 10/2016
4	Transcription Factors (Transcription Factor)IBA 11/2021 - 09/2015
4	Cytarabine (Cytosar-U)FDA LinkGeneric 09/2021 - 05/2016
4	EpitopesIBA 08/2021 - 10/2009
3	Vincristine (Oncovin)FDA LinkGeneric 02/2022 - 08/2016
3	AntigensIBA 01/2021 - 01/2010
3	Thymidine KinaseIBA 01/2020 - 01/2017
3	neurabinIBA 01/2020 - 12/2018
3	Messenger RNA (mRNA)IBA 01/2019 - 01/2004
3	CytokinesIBA 01/2018 - 03/2011
3	Methotrexate (Mexate)FDA LinkGeneric 11/2017 - 05/2016
3	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 11/2017 - 05/2016
2	tirabrutinibIBA 06/2022 - 04/2022
2	Immunoglobulin G (IgG)IBA 01/2022 - 08/2021
2	Interleukin-10 (Interleukin 10)IBA 12/2021 - 01/2021
2	Interleukin-10 ReceptorsIBA 12/2021 - 01/2021
2	acalabrutinibIBA 11/2021 - 01/2021
2	Interferon-alpha (Interferon Alfa)IBA 09/2021 - 01/2020
2	serum P-component (CIt)IBA 05/2021 - 01/2018
2	ExotoxinsIBA 01/2020 - 12/2018
2	duvelisibIBA 01/2020 - 12/2018
2	AntibodiesIBA 01/2020 - 01/2018
2	ProgranulinsIBA 06/2019 - 01/2013
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2019 - 12/2018
2	Phospholipases (Phospholipase)IBA 09/2018 - 10/2016
2	RNA (Ribonucleic Acid)IBA 11/2016 - 09/2015
2	CreatinineIBA 08/2016 - 02/2006
2	Cisplatin (Platino)FDA LinkGeneric 08/2016 - 06/2016
2	Long Noncoding RNAIBA 09/2015 - 04/2013
2	NF-kappa B (NF-kB)IBA 04/2013 - 04/2011
2	Monoclonal AntibodiesIBA 10/2011 - 10/2009
2	ChemokinesIBA 03/2011 - 06/2010

Therapy/Procedure

48	Therapeutics 01/2022 - 04/2004
24	Drug Therapy (Chemotherapy) 02/2022 - 08/2002
16	Stem Cell Transplantation 09/2021 - 03/2003
5	Transplantation 01/2019 - 11/2008
4	Immunotherapy 12/2021 - 04/2010
4	Hematopoietic Stem Cell Transplantation 01/2020 - 11/2008
3	Cell Transplantation 01/2022 - 12/2016
3	Radiotherapy 12/2019 - 05/2016
2	Salvage Therapy 01/2022 - 01/2019
2	Aftercare (After-Treatment) 01/2018 - 01/2016